Skip to main content

Anti-NMDA Receptor Encephalitis clinical trials at UCSF

1 research study open to eligible people

Anti-NMDA receptor encephalitis is a type of brain illness. At UCSF, we are testing a drug named Satralizumab to see if it can help patients with this condition. We're studying its safety and how it affects the body.

Showing trials for

Last updated: